These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34299145)

  • 1. Diagnostic Tools and Biomarkers for Severe Drug Eruptions.
    Yoshioka M; Sawada Y; Nakamura M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous reactions to drugs].
    Mulder WM; Meinardi MM; Bruynzeel DP
    Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse cutaneous drug eruptions: current understanding.
    Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
    J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxic epidermal necrolysis (Lyell syndrome), a lifethreatening emergency of introgenic origin].
    Piérard GE; Jennes S; Piérard-Franchimont C
    Rev Med Liege; 2016 Oct; 71(10):435-439. PubMed ID: 28383851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of severe cutaneous drug eruptions.
    Bachot N; Roujeau JC
    Am J Clin Dermatol; 2003; 4(8):561-72. PubMed ID: 12862499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
    Darlenski R; Kazandjieva J; Tsankov N
    Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annular drug eruptions.
    Wu WH; Chu CY
    Clin Dermatol; 2022; 40(5):450-465. PubMed ID: 34979270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic criteria for cutaneous adverse drug reactions].
    Aihara M
    Arerugi; 2012 Aug; 61(8):1061-6. PubMed ID: 23089970
    [No Abstract]   [Full Text] [Related]  

  • 11. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.
    Anderson HJ; Lee JB
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases.
    Bellón T; Alvarez L; Mayorga C; Morel E; Torres MJ; Martín-Díaz MA; Díaz R; Radial A; Carballo M; Blanca M
    Br J Dermatol; 2010 May; 162(5):1014-22. PubMed ID: 20030638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 14. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders.
    Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH;
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening acute adverse cutaneous drug reactions.
    Wolf R; Orion E; Marcos B; Matz H
    Clin Dermatol; 2005; 23(2):171-81. PubMed ID: 15802211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions.
    Chu MT; Wang CW; Chang WC; Chen CB; Chung WH; Hung SI
    J Invest Dermatol; 2021 Jun; 141(6):1461-1472.e10. PubMed ID: 33340500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD; Schafer PA
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC
    Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.